Cargando…
Pseudoprogression of thoracic tumor after radiotherapy in the era of immunotherapy: a case series
Pseudoprogression is rarely mentioned after radiotherapy except for central nervous system tumors. With the widespread of immunotherapy, the incidence of pseudoprogression of thoracic tumor after radiotherapy is increasing. This study summarized the clinical features of pseudoprogression in 4 patien...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10419187/ https://www.ncbi.nlm.nih.gov/pubmed/37576884 http://dx.doi.org/10.3389/fonc.2023.1021253 |
_version_ | 1785088455259193344 |
---|---|
author | Xiang, Yongbo Tang, Wei Wang, Jianyang Wang, Zhijie Bi, Nan |
author_facet | Xiang, Yongbo Tang, Wei Wang, Jianyang Wang, Zhijie Bi, Nan |
author_sort | Xiang, Yongbo |
collection | PubMed |
description | Pseudoprogression is rarely mentioned after radiotherapy except for central nervous system tumors. With the widespread of immunotherapy, the incidence of pseudoprogression of thoracic tumor after radiotherapy is increasing. This study summarized the clinical features of pseudoprogression in 4 patients who had underwent thoracic radiotherapy after and/or followed by immunotherapy. All of them had received chemotherapy and immunotherapy before thoracic radiotherapy. After radiotherapy, pseudoprogression occurred within 3 months after initiation of immune consolidation/rechallenge therapy. At least a 20% increase in the sum of the longest diameter of target lesions were measured on their chest image. During this period, patients’ ECOG PS scores remained stable, specific serum tumor markers did not increase significantly. Treatment strategies did not change after pseudoprogression. The causes of radiographic pseudoprogression in this case series may be attributed to disturbances such as pneumonitis, atelectasis, mucus blockages and infection. In the era of immunotherapy, pseudoprogression of thoracic tumors after chest radiotherapy might become a common phenomenon. It is important for us to identify pseudoprogression based on patient’s general status, radiological changes, and laboratory tests. |
format | Online Article Text |
id | pubmed-10419187 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-104191872023-08-12 Pseudoprogression of thoracic tumor after radiotherapy in the era of immunotherapy: a case series Xiang, Yongbo Tang, Wei Wang, Jianyang Wang, Zhijie Bi, Nan Front Oncol Oncology Pseudoprogression is rarely mentioned after radiotherapy except for central nervous system tumors. With the widespread of immunotherapy, the incidence of pseudoprogression of thoracic tumor after radiotherapy is increasing. This study summarized the clinical features of pseudoprogression in 4 patients who had underwent thoracic radiotherapy after and/or followed by immunotherapy. All of them had received chemotherapy and immunotherapy before thoracic radiotherapy. After radiotherapy, pseudoprogression occurred within 3 months after initiation of immune consolidation/rechallenge therapy. At least a 20% increase in the sum of the longest diameter of target lesions were measured on their chest image. During this period, patients’ ECOG PS scores remained stable, specific serum tumor markers did not increase significantly. Treatment strategies did not change after pseudoprogression. The causes of radiographic pseudoprogression in this case series may be attributed to disturbances such as pneumonitis, atelectasis, mucus blockages and infection. In the era of immunotherapy, pseudoprogression of thoracic tumors after chest radiotherapy might become a common phenomenon. It is important for us to identify pseudoprogression based on patient’s general status, radiological changes, and laboratory tests. Frontiers Media S.A. 2023-07-28 /pmc/articles/PMC10419187/ /pubmed/37576884 http://dx.doi.org/10.3389/fonc.2023.1021253 Text en Copyright © 2023 Xiang, Tang, Wang, Wang and Bi https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Oncology Xiang, Yongbo Tang, Wei Wang, Jianyang Wang, Zhijie Bi, Nan Pseudoprogression of thoracic tumor after radiotherapy in the era of immunotherapy: a case series |
title | Pseudoprogression of thoracic tumor after radiotherapy in the era of immunotherapy: a case series |
title_full | Pseudoprogression of thoracic tumor after radiotherapy in the era of immunotherapy: a case series |
title_fullStr | Pseudoprogression of thoracic tumor after radiotherapy in the era of immunotherapy: a case series |
title_full_unstemmed | Pseudoprogression of thoracic tumor after radiotherapy in the era of immunotherapy: a case series |
title_short | Pseudoprogression of thoracic tumor after radiotherapy in the era of immunotherapy: a case series |
title_sort | pseudoprogression of thoracic tumor after radiotherapy in the era of immunotherapy: a case series |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10419187/ https://www.ncbi.nlm.nih.gov/pubmed/37576884 http://dx.doi.org/10.3389/fonc.2023.1021253 |
work_keys_str_mv | AT xiangyongbo pseudoprogressionofthoracictumorafterradiotherapyintheeraofimmunotherapyacaseseries AT tangwei pseudoprogressionofthoracictumorafterradiotherapyintheeraofimmunotherapyacaseseries AT wangjianyang pseudoprogressionofthoracictumorafterradiotherapyintheeraofimmunotherapyacaseseries AT wangzhijie pseudoprogressionofthoracictumorafterradiotherapyintheeraofimmunotherapyacaseseries AT binan pseudoprogressionofthoracictumorafterradiotherapyintheeraofimmunotherapyacaseseries |